Journal of Stem Cells Research Development & Therapy Category: Medical Type: Commentary

Mechanical and Thermodynamic Properties of Mesenchymal Stem Cells Differentiated into Myofibroblasts: A Commentary on the Article “Statistical Mechanics of Non-Muscle Myosin IIA in Human Bone Marrow-Derived Mesenchymal Stromal Cells Seeded in a Collagen Scaffold: A Thermodynamic Near-Equilibrium Linear System Modified by the Tripeptide Arg-Gly-Asp (RGD)”

Yves Lecarpentier1*, Olivier Schussler2 and Alexandre Vallée3
1 Centre de recherche clinique, Grand Hôpital de l’Est Francilien, 77104 Meaux, France
2 Département de Chirurgie Thoracique, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes Université, 75014, France
3 Department of clinical research and innovation, Foch Hospital, 92150, Suresnes, France

*Corresponding Author(s):
Yves Lecarpentier
Centre De Recherche Clinique, Grand Hôpital De L’Est Francilien, 77104 Meaux, France

Received Date: Jun 17, 2021
Accepted Date: Jun 25, 2021
Published Date: Jul 02, 2021


Mesenchymal Stem Cells (MSCs) are multipotent stromal cells found in bone marrow and have the capacity to differentiate into myofibroblast. In contractile myofibroblasts, the molecular motor is the non-muscle myosin (NMIIA) which differs from the muscle myosin by its ultra-slow kinetics. The differentiation of MSCs into myofibroblasts is promoted by the “Transforming Growth Factor” (TGF-b) which represents a potentially target against tissue fibrosis and cancer. Myofibroblasts have been discovered by Gabbiani et al. [1,2] and are physiologically found in certain organs such as human placenta. They also play a key role in inflammatory and fibrotic processes and cancer stroma. They exhibit contractile properties qualitatively similar to those observed in muscles. However, quantitatively they are strongly different. Thus, their mechanical and thermodynamic properties are dramatically low compared to what is observed in skeletal or smooth muscles.


Multipotent Mesenchymal Stem Cells (MSCs) are found in bone marrow and in other tissues including cord blood, peripheral blood, and fetal lung and liver. They can differentiate into various cell types, including adipocytes, chondrocytes, osteoblasts, and myocytes. MSCs have a great capacity for self-renewal while maintaining their multipotency. They play a key role in making and repairing skeletal tissues, bone, cartilage and fat. MSCs can also undergo a myofibroblast differentiation, conjointly with the production of alpha Smooth Muscle Actin (α-SMA) in response to stimulation by means of the transforming growth factor-β (TGF-β). Myofibroblasts also play a fundamental role in tissue repair processes, inflammatory processes, fibrosis (heart, lung, kidney, liver, etc.) and cancer stroma. 

The presence of myofibroblasts in either physiological or pathological tissues gives them surprising contractile properties. These tissues are not muscles but present contractile properties qualitatively similar to those of muscles. These “non-muscles” contain numerous myofibroblasts [1,2]. Their molecular motor is the non-muscle myosin type IIA (NMIIA), whose the main characteristic is the dramatic slowness of molecular kinetics. Myofibroblasts are present in physiological tissues (human placenta) [3], in pathological tissues (fibrosis, inflamed tissues and cancer stroma [4,5] and in engineered tissues [6].  Although mechanical and thermodynamic properties of striated (skeletal and cardiac) and smooth muscles have been thoroughly described for a long time, those of non-muscle tissues remain relatively poorly reported. Similarly to muscles, non-muscle contractile tissues present four mechanical properties: i) they contract after electrical stimulation or in presence of KCl; ii) they relax by either decreasing the intracellular calcium concentration (isosorbide dinitrate (ISDN), Sildenafil) or inhibiting actin-myosin interactions; iii) they obey the Frank-Starling law [7,8], which specifies that when the initial length of contractile fibers increases, the developed tension increases; iv), they present the hyperbolic relationship between the maximum shortening velocity (V) and the level of isotonic tension (T) reported by Hill AV [9]. This property is of great importance because it allows to apply the phenomenological theory of muscle contraction due to A. Huxley [10] and to determine the molecular kinetics of actin-myosin Cross Bridges (CBs) [11]. The curvature of the T-V relationship can be introduced in Huxley’s equations [10] and makes it possible to determine the molecular properties of the molecular motor, namely: average individual force generated by a single actin-myosin interaction, number of active actin-myosin CBs, kinetics of attachment and detachment of CB, maximum myosin ATPase activity, total myosin content and maximum efficiency of the actin-myosin interaction.  In statistical mechanics, the huge number of myosin heads in muscles and non-muscle contractile issues makes it possible to apply the formalism of the grand canonical ensemble. This allows to determine the thermodynamic quantities namely: statistical entropy, internal energy, chemical affinity, thermodynamic force, thermodynamic flow and rate of entropy production. Normal striated and smooth muscles operate near equilibrium and in a linear stationary fashion. This means that the thermodynamic force linearly varies with the thermodynamic flow [12,13]. 

Besides muscles, non-muscle contractile tissues also exhibit contractile properties. One of these tissues is the human placenta, in which cells show mechanical similarities to smooth muscle cells [14]. The human term placenta presents an important source of pluripotent adult stem cells [15,16]. MSCs isolated from the placenta show similar characteristics to widely used bone marrow-derived MSCs [17]. Human placental villi are able to contract after stimulation with KCl [18-20]. Human placenta is a non-muscle contractile organ. It can contract due to the presence of numerous myofibroblasts contained in the placental villi [3]. The molecular motor is NMIIA [21]. Mechanical and thermodynamic properties of human placenta can be studied by using the same techniques than those used for muscle tissues [22-24]. They are qualitatively similar to those of muscles. Thus, contraction of the placental villi can be triggered by an electric field or after KCl exposure. Likewise, relaxation is induced in both contractile systems by the reuptake of calcium by the sarco-endoplasmic reticulum or by CB inhibition. The Frank-Starling phenomenon and the hyperbolic relation T-V are also observed. However, the molecular characteristics of NMIIA are quite different from those of muscles. The major mechanical difference between muscles and non-muscle contractile tissues is that non-muscle contractile tissues present mechanical properties dramatically slow compared with those of muscle myosins and develop less tension. In addition, molecular kinetics of NMIIA and maximum ATPase activity are extremely low compared with than those of muscle myosins. However, the force developed by a single actin-myosin interaction and the thermodynamic efficiency of the CB interaction are of same order of magnitude as that determined in both muscles and non-muscle contractile systems [13].

 There are other non-muscular contractile systems besides the placenta. We recently showed that Mesenchymal Stem Cells (MSCs) derived from human bone marrow taken from femoral heads obtained after fractures of the femoral neck and included in collagen scaffolds in the presence of TGF-b1, exhibited the same mechanical and thermodynamic properties as those of the human placenta [6]. Under these conditions, MSCs differentiate into myofibroblasts. Mechanical and thermodynamic properties of MSCs included in collagen scaffolds are similar to those of the human placenta. Like human placenta, they contract after electrical stimulation or KCl exposure, they relax under ISDN or Sildenafil, they present the Frank-Starling law and the T-V hyperbolic relationship [25,26]. The differentiation of fibroblasts into myofibroblasts is largely regulated by TGF-b1. TGF-b1 upregulates the canonical Wnt/b-catenin pathway positively, and downregulates the peroxisome proliferator activated receptor gamma (PPARg). The Wnt/b-catenin signaling promotes tissue fibrosis while PPARg prevents it [4]. Thus, TGF-b1 promotes the onset of fibrosis in the heart, lungs, liver and kidneys. Conversely, PPARg opposes the canonical Wnt signaling and tends to limit the processes of fibrosis. Myofibroblasts have been found in many fibrous diseases such as systemic sclerosis, idiopathic pulmonary fibrosis, cirrhosis of the liver, heart failure and myocardial infarction. They are also present in cancer stroma [27], retinal detachment and anterior capsular cataract. Chronic inflammatory lesions cause prolonged activation of fibroblasts which then differentiate into myofibroblasts. These can persist after a skin wound has closed, leading to a hypertrophic scar, especially in burns [28]. PPARg agonists can interrupt or prevent the profibrotic effects of TGF-β1, and the differentiation of fibroblasts into myofibroblasts. These mechanisms potentially represent interesting therapeutic targets in the fight against cancer and fibrosis.


Non-muscle contractile tissues containing a sufficient population of myofibroblasts acquire contractile properties qualitatively similar to those of muscles. However, their NMIIA molecular motor exhibits ultra-slow kinetics but develops elemental force of same order of magnitude compared with those of muscle myosins. Thermodynamically, the non-muscle contractile tissues operate near equilibrium in a stationary linear mode. The central role of myofibroblasts [29] reflects the interest of better understanding the contractile mechanisms of non-muscle tissues involved in tissue repair processes [30] but also in fibrosis [31] and cancers [32].


  1. Gabbiani G, Ryan GB, Majne G (1971) Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27: 549-550.
  2. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G (1972) Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 135: 719-734.
  3. Feller AC, Schneider H, Schmidt D, Parwaresch MR (1985) Myofibroblast as a major cellular constituent of villous stroma in human placenta. Placenta 6: 405-415.
  4. Vallee A, Lecarpentier Y, Guillevin R, Vallee JN (2017) Interactions between TGF-beta1, canonical WNT/beta-catenin pathway and PPAR gamma in radiation-induced fibrosis. Oncotarget 8: 90579-90604.
  5. Vallee A, Lecarpentier Y (2019) TGF-beta in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci 9: 98.
  6. Lecarpentier Y, Schussler O, Sakic A, Rincon-Garriz JM, Soulie P, et al. (2018) Human Bone Marrow Contains Mesenchymal Stromal Stem Cells That Differentiate In Vitro into Contractile Myofibroblasts Controlling T Lymphocyte Proliferation. Stem Cells Int 2018: 6134787.
  7. Frank O (1895) Zur Dynamik des Herzmuskels. Z Biol 32: 370-437.
  8. Starling EH (1918) The Linacre Lecture on the Law of the Heart. Longmans, Green & Co, London.
  9. Hill AV (1938) The heat of shortening and the dynamic constants of muscle. Proc R Soc Lond Biol Sci 126: 136-195.
  10. Huxley AF (1957) Muscle structure and theories of contraction. Prog Biophys Biophys Chem 7: 255-318.
  11. Lecarpentier Y, Chemla D, Blanc FX, Pourny JC, Joseph T, et al. (1998) Mechanics, energetics, and crossbridge kinetics of rabbit diaphragm during congestive heart failure. Faseb J 12: 981-989.
  12. Prigogine I, Nicolis G, Babloyantz A (1974) Nonequilibrium problems in biological phenomena. Ann N Y Acad Sci 231: 99-105.
  13. Lecarpentier Y, Claes V, Krokidis X, Hébert JL, Timbely O, et al. (2017) Comparative Statistical Mechanics of Muscle and Non-Muscle Contractile Systems: Stationary States of Near-Equilibrium Systems in A Linear Regime. Entropy 19: 558.
  14. Dubreuil G, Rivière M (1932) Formations fibromusculaires du chorion et villosités du placenta humain. C R Soc Biol 111: 170-172.
  15. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FHJ, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338-1345.
  16. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, et al. (2007) Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75: 279-291.
  17. Strakova Z, Livak M, Krezalek M, Ihnatovych I (2008) Multipotent properties of myofibroblast cells derived from human placenta. Cell Tissue Res 332: 479-488.
  18. Krantz EK, Parker JC (1963) Contractile properties of the smooth muscle in the human placenta. Clin Obstet Gynecol 6: 26-38.
  19. King TM, Groeschel-Stewart U (1965) Placental Contractile Protein. Am J Obstet Gynecol 93: 253-258.
  20. Farley AE, Graham CH, Smith GN (2004) Contractile properties of human placental anchoring villi. Am J Physiol Regul Integr Comp Physiol 287: R680-R685.
  21. Matsumura S, Sakurai K, Shinomiya T, Fujitani N, Key K, et al. (2011) Biochemical and immunohistochemical characterization of the isoforms of myosin and actin in human placenta. Placenta 32: 347-355.
  22. Lecarpentier E, Claes V, Timbely O, Hebert JL, Arsalane A, et al. (2013) Role of both actin-myosin cross bridges and NO-cGMP pathway modulators in the contraction and relaxation of human placental stem villi. Placenta 34: 1163-1169.
  23. Lecarpentier Y, Claes V, Lecarpentier E, Guerin C, Hebert JL, et al. (2014) Ultraslow myosin molecular motors of placental contractile stem villi in humans. PLoS One 9: e108814.
  24. Lecarpentier Y, Claes V, Hebert JL, Krokidis X, Blanc FX, et al. (2015) Statistical Mechanics of the Human Placenta: A Stationary State of a Near-Equilibrium System in a Linear Regime. PLoS One 10: e0142471.
  25. Lecarpentier Y, Kindler V, Bochaton-Piallat ML, Sakic A, Claes V, et al. (2019) Tripeptide Arg-Gly-Asp (RGD) modifies the molecular mechanical properties of the non-muscle myosin IIA in human bone marrow-derived myofibroblasts seeded in a collagen scaffold. PLoS One 14: e0222683.
  26. Lecarpentier Y, Kindler V, Krokidis X, Bochaton-Piallat ML, Claes V, et al. (2020) Statistical Mechanics of Non-Muscle Myosin IIA in Human Bone Marrow-Derived Mesenchymal Stromal Cells Seeded in a Collagen Scaffold: A Thermodynamic Near-Equilibrium Linear System Modified by the Tripeptide Arg-Gly-Asp (RGD). Cells 9: 1510.
  27. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, et al. (2012) Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180: 1340-1355.
  28. Hinz B (2016) The role of myofibroblasts in wound healing. Curr Res Transl Med 64: 171-177.
  29. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, et al. (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170:1807-1816.
  30. Gabbiani G (1977) Reparative processes in mammalian wound healing: the role of contractile phenomena. Int Rev Cytol 48: 187-219.
  31. Hinz B (2012) Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast. Proc Am Thorac Soc 9: 137-147.
  32. Lecarpentier Y, Schussler O, Hebert JL, Vallee A (2019) Multiple Targets of the Canonical WNT/beta-Catenin Signaling in Cancers. Front Oncol 9: 1248.

Citation: Lecarpentier Y, Schussler O, Vallée A (2021) Mechanical and Thermodynamic Properties of Mesenchymal Stem Cells Differentiated into Myofibroblasts: A Commentary on the Article “Statistical Mechanics of Non-Muscle Myosin IIA in Human Bone Marrow-Derived Mesenchymal Stromal Cells Seeded in a Collagen Scaffold: A Thermodynamic Near-Equilibrium Linear System Modified by the Tripeptide Arg-Gly-Asp (RGD)”. J Stem Cell Res Dev Ther 7: 075.

Copyright: © 2021  Yves Lecarpentier, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Herald Scholarly Open Access is a leading, internationally publishing house in the fields of Sciences. Our mission is to provide an access to knowledge globally.

© 2023, Copyrights Herald Scholarly Open Access. All Rights Reserved!